Novel applications of dds on infectious diseases and future prospect “drug delivery system responding to cellular signals in infected cells”

Yoko Shoji, Hideki Nakashima, Kouta Kodama, Yoshiki Katayama

Research output: Contribution to journalArticle

Abstract

In this study, we designed a peptide which is specifically cleaved by HIV protease as a gene/drug carrier. This is based on a new concept of a drug delivery system (DDS) responding to intracellular signals. We observed that this peptide was cleaved by recombinant HIV protease and HIV infected cells. In this system, the gene/drug can be released only in HIV infected cells. Since drugs could be activated only in infected cells, this system has a potential to raise the efficacy of drugs and reduce their side effects. As a biological signal, nitric oxide (NO) has aroused much attention. NO is a promising biological signal as well as a HIV protease in the new concept of DDS. However, it is extremely difficult to measure directly because of extreme short half-life time. We will introduce our system to measure NO directly by an electrode method.

Original languageEnglish
Pages (from-to)505-515
Number of pages11
JournalDrug Delivery System
Volume21
Issue number5
DOIs
Publication statusPublished - Jan 1 2006

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Novel applications of dds on infectious diseases and future prospect “drug delivery system responding to cellular signals in infected cells”'. Together they form a unique fingerprint.

  • Cite this